LESLIE CHAMBERS: Open Payments
NPI 1710345442 · BRYANT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 40 payments from 13 companies in 2025. Trend: 2023 $563 · 2024 $694 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 5 | $102 |
| Astellas Pharma US Inc | 4 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| ABBVIE INC. | 4 | $78 |
| SHIELD THERAPEUTICS INC | 4 | $73 |
| MAYNE PHARMA COMMERCIAL LLC | 9 | $52 |
| MILLICENT US INC | 2 | $40 |
| Organon LLC | 2 | $39 |
| Exeltis, USA Inc. | 2 | $31 |
| PFIZER INC. | 1 | $18 |
Products named: ZURZUVAE, Veozah, Mirena, ACCRUFER, NEXPLANON, UBRELVY, SLYND, INTRAROSA.
Industry payments across AR — which companies pay providers there.
